Emerald Health Sciences Inc.

Overview

• HeadquartersA1¹
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Corporate structure

Emerald Health Sciences Inc. sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive Officer, DirectorJim Heppell named Sep 1, 2022²
• Executive OfficerStephen Hall named Sep 1, 2022²
• DirectorGaetano Morello named Sep 1, 2022²

Filings

6 filings to the SEC since October 2021: 6 private raises. The latest 6:

1. Sep 1, 2022D EDGAR
2. Sep 1, 2022D EDGAR
3. Sep 1, 2022D EDGAR
4. Sep 1, 2022D EDGAR
5. Sep 1, 2022D EDGAR
6. Sep 1, 2022D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Emerald Health Sciences Inc. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Skye Bioscience, Inc.SC 13D/A Jan 31, 2022 to Mar 20, 2023³

Money raised

Private offerings the company reported to the SEC on Form D.

1. Jan 8, 2019Raised $360,000 in a private offering of equity Form D: 2 investors so far Form D
2. Apr 18, 2017Raised $4 million in a private offering of equity Form D: 45 investors so far Form D
3. Dec 31, 2015Raised $9.9 million in a private offering of equity Form D: 39 investors so far Form D
4. Jul 10, 2015Raised $392,956 in a private offering of equity Form D: 5 investors so far Form D
5. Dec 29, 2014Raised $500,430 in a private offering of equity Form D: 10 investors so far Form D
6. Nov 15, 2013Raised $65,509 in a private offering of equity Form D: 6 investors so far Form D